Research identifies possible new pathway to treatment of colorectal cancer
A paper published in May in the American Gastroenterological Association journalCellular and Molecular Gastroenterology and Hepatology focusses on…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
The OJC Episode 6: ASCO Special Episode Part 1
Welcome to Episode 6 of the second series of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson for the first ASCO 2024 Special.
Rapid test of cerebrospinal fluid decreases time to diagnosis for brain tumours
A test that looks for genetic hallmarks of brain cancers in samples of cerebrospinal fluid…
How targeted nutrients can treat cancer
Aussie researchers have discovered a new way to effectively treat cancer, by using nutrients to…
Social inequalities widen after a breast cancer
When it comes to health, inequalities can be seen at every level for women with…
Johnson & Johnson face new class action over talc products
Johnson & Johnson is confronted with a new class action lawsuit that demands damages and…
Fasting primes the immune system’s natural killer cells to better target cancer, new study in mice finds
Periods of fasting reprogram the immune system’s natural killer cells to better fight cancer, according…
Nano-immunotherapy developed to improve lung cancer treatment
Researchers have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells…
Researchers discover promising approach to prevent recurrence of breast cancer
Treatment outcomes for breast cancer have become better over the years, but proportion of breast…
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL)
This content is password-protected. To view it, please enter the password below. Password: